Â鶹´«Ã½Ó³»­

Â鶹´«Ã½Ó³»­

Explore the latest content from across our publications
Join The Â鶹´«Ã½Ó³»­

Log In

Forgot Password?
Create New Account

Loading... please wait

2011 Annual Meeting | Myelopathies

Saturday 04/16/11
09:00 AM - 01:00 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
AM Half-Day Course
Neeraj Kumar, MD
Participants should be able to confidently diagnose the wide spectrum of disorders of the spinal cord and have a practical approach toward the work-up and management of these patients; be aware of the recent advances in conditions like neuromyelitis optica, copper deficiency myelopathy, hereditary spastic paraplegia, myelopathies related to spinal dural arteriovenous fistulas, and paraneoplastic myelopathies; and know the recommendations regarding use of steroids in compressive myelopathies.
No CME available
Patient Care & Procedural Skills, Medical Knowledge
Trainee, General Neurologist
Case-based, Didactic
Event Timeline
09:00 AM - 09:50 AM Spinal Cord Syndromes and Vascular Myelopathies
Jose Biller, MD, FACP, FAHA, FÂ鶹´«Ã½Ó³»­
09:50 AM - 10:40 AM Inflammatory and Infectious Myelopathies
Dean M. Wingerchuk, MD, FÂ鶹´«Ã½Ó³»­
10:40 AM - 11:00 AM Break
11:00 AM - 11:50 AM Metabolic and Hereditary Myelopathies
Neeraj Kumar, MD
11:50 AM - 12:40 AM Neoplastic and Other Compressive Myelopathies
Julie E. Hammack, MD, FÂ鶹´«Ã½Ó³»­
12:40 PM - 01:00 PM Panel Discussion
Faculty Disclosures
Jose Biller, MD, FACP, FAHA, FÂ鶹´«Ã½Ó³»­ Dr. Biller has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters Kluwer. Dr. Biller has received publishing royalties from a publication relating to health care.
Dean M. Wingerchuk, MD, FÂ鶹´«Ã½Ó³»­ Dr. Wingerchuk has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Dr. Wingerchuk has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Wingerchuk has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Meyer Squibb. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Wingerchuk has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca. Dr. Wingerchuk has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abcuro. Dr. Wingerchuk has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters Kluwers.
Neeraj Kumar, MD Dr. Kumar has nothing to disclose.
Julie E. Hammack, MD, FÂ鶹´«Ã½Ó³»­ Dr. Hammack has nothing to disclose.